Thirty-six specific-pathogen-free pigs were weaned at 2 weeks of age and separated into 4 treatment groups (A-D, 9 pigs/group). Treatment groups B and D were infected with porcine reproductive and respiratory syndrome virus (PRRSV), whereas groups A and C remained uninfected. Two weeks later, 1 pig from each group was necropsied to assess gross lung involvement, and then the remaining group D PRRSVinfected pigs and the group C uninfected pigs were challenged at 4 weeks of age with transmissible gastroenteritis virus (TGEV) to determine if prior infection with PRRSV increased the severity of TGEV disease after challenge. One hundred percent morbidity but no mortality occurred in pigs following challenge. Clinically, pigs of both groups C and D were similar in terms of onset and severity of diarrhea. The serum antibody response to TGEV and the amount and duration of TGEV shedding after challenge was similar for both groups. Only a few pigs in each group had a transient fever postchallenge, and both group C and group D pigs began to recover and to gain weight at or near the end of the first week postchallenge. It was concluded that the clinical course of TGEV disease was not markedly affected by infection of pigs with TGEV 2 weeks after they had been infected with PRRSV.
Porcine reproductive and respiratory syndrome (PRRS) is characterized by reproductive failure in gilts and sows and by weakened neonatal piglets. 26 Moreover, the PRRS virus (PRRSV) is believed to contribute to the respiratory disease complex in nursery-age and finishing pigs. Since 1987, when the disease was first described in the United States, 6 PRRS has resulted in significant economic loss to swine producers worldwide. As a consequence, PRRS has become the focus of intense veterinary research.
Experimental infection of young pigs with US strains of PRRSV causes mild to severe interstitial pneumonia, a persistent viremia, enlarged lymph nodes, and persistence of PRRSV in tonsils and alveolar macrophages. 4, 13, 20, 23 The pathogenesis of reproductive failure is unknown, but recent experimental studies suggest that umbilical cord and fetal tissue vascular lesions may contribute to the death of the fetus. 8 The major sites of PRRSV replication are alveolar macrophages and lymphoid cells. During acute PRRSV infections, the percentage of alveolar macrophages is reduced by cell lysis and their function is altered, but the humoral antibody response and cellmediated immunity is not impaired. 1, 15 However, many clinical observations by veterinarians in the field indicate that PRRSV infection predisposes nursery-age and finishing pigs to secondary bacterial or viral pneu-From the Virology Swine Research Unit, National Animal Disease Center, Agricultural Research Service, USDA, Ames, IA 50010.
Received for publication November 3, 1997. monia. 5, 10, 14, 18, 25 Whether this effect is localized to the respiratory tract or due to a general immunosuppression induced by PRRSV is unknown. 16 To test whether prior infection of pigs with PRRSV affects the severity of disease at a nonrespiratory site, PRRSV-infected and control pigs at 4 weeks of age were challenged with transmissible gastroenteritis virus (TGEV). This virus infects epithelial cells of the small intestine, causing severe and often fatal diarrhea in pigs Ͻ2 weeks of age. In pigs 1 month of age, TGEV-induced gastroenteritis is still severe but not usually fatal. Thus, if immunosuppression occurs in 1month-old pigs because of prior infection with PRRSV, then the effects of TGEV challenge could be quite dramatic and even fatal. However, if the effects of PRRSV infection are restricted to the respiratory tract, then there would be little if any effect on the course of TGEV.
Materials and methods
Viruses and cell culture. The PRRSV strain (NADC-8) used in this study was obtained from an infected herd in Iowa. 9 The MARC-145 cell line was used to propagate PRRSV. 7 The MARC-145 cells were grown in Earle's minimum essential medium supplemented with 10% fetal bovine serum (FBS) and gentamicin sulfate (50 g/ml).
The TGEV Miller strain (p439) was prepared as an intestinal homogenate and stored in liquid nitrogen. 22 After thawing, the TGEV homogenate was diluted in phosphate-buffered saline, sonicated briefly to dissociate virus aggregates, and diluted in cold growth medium containing 2% FBS. Swine testicular (ST) cells were used for propagation of Figure 1 . The average daily weight gain of pigs during the first week after exposure to PRRSV. A. Pigs of groups B and D exposed to PRRSV. B. Pigs of groups A and C not exposed to PRRSV.
TGEV. The ST cells were grown in modified Eagle's minimal essential medium (EMEM) supplemented with 10% FBS, lactalbumin hydrolysate (0.25%), sodium bicarbonate (0.22%), sodium pyruvate (0.01%), and gentamicin sulfate (50 g/ml).
Experimental design. Four pregnant gilts were purchased from a specific-pathogen-free (SPF) herd and farrowed in separate isolation rooms in a clean environment at the National Animal Disease Center (Ames, IA). Sera from these gilts obtained prior to purchase and again at the time of farrowing were negative for both TGEV and PRRSV antibodies by neutralization and indirect fluorescent antibody tests, respectively. The gilts farrowed during a 4-day period: 1 litter late Sunday, 1 litter on Wednesday, and 2 litters on Tuesday. For this experiment, Tuesday was considered day 0 or the day of birth for all the pigs.
The pigs suckled their respective dams until 2 wk of age, when they were weaned and arranged into 4 treatment groups (A-D). Each group, housed in a separate isolation room under negative pressure air flow, consisted of at least 2 pigs (a male and a female) from each litter. Each treatment group consisted of 9 pigs; group A pigs (controls) were given no virus, group B pigs were given PRRSV only, group C pigs were given TGEV only, and group D pigs were given PRRSV followed 2 wk later by TGEV. Two groups (B, D) received 2 ml/pig of PRRSV (6 ϫ 10 6 TCID 50 /pig) intranasally at 2 wk of age. Blood was collected from all pigs prior to exposure to PRRSV and weekly thereafter. All pigs were observed twice daily for clinical signs, and during the next 2 wk body weight and body temperature were determined intermittently. One pig from each group was necropsied 15 days following PRRSV exposure to examine lungs and lymph nodes.
At 4 wk of age, the pigs in groups C and D received 1.8 ϫ 10 5 plaque-forming units of TGEV in a volume of 5 ml administered via stomach tube. All pigs were observed twice daily for clinical signs, and body weight and body temperature were determined daily. Rectal swab samples were collected after challenge, and the TGEV titer was determined for each sample.
PRRSV recovery from serum samples. Isolation of PRRSV was carried out essentially as described previously. 12 TGEV recovery from rectal swabs. Rectal swab samples were collected from pigs at the time of challenge and on days 1, 2, 3, 4, 5, 7, and 10 postchallenge. Rectal swabs were placed in 1 ml of cold EMEM supplemented with FBS (20%), penicillin (25 U/ml), streptomycin (25 g/ml), neomycin sulfate (25 g/ml), bacitracin (0.25 U/ml), and gentamicin sulfate (50 g/ml) and stored frozen at Ϫ70 C. Swab samples were thawed, squeezed with sterile forceps, and centrifuged at low speed to remove debris. Each sample supernatant was diluted in a 5-fold dilution series, and 100-l aliquots of each dilution were applied in quadruplicate to confluent ST cells on a 48-well plate. The inoculum was removed after 1 hr, and 0.4 ml/well of EMEM containing FBS (2%), antibiotics at concentrations listed above, porcine antisera against enterovirus and rotavirus (0.1%), and fungizone (2.5 g/ml) was added. The plates were incubated at 37 C in a humidified CO 2 incubator and then observed by light microscopy for cytopathic effect after 4-6 days. Each sample dilution was passed a total of 3 times on ST cells to insure detection of TGEV. The TCID 50 for each sample was calculated as previously described. 17 Serology. Serum samples were heat inactivated at 56 C for 30 min. TGEV neutralizing antibody titers were determined by a 50% plaque reduction test on ST cells. 24 Antibody titers to PRRSV were measured by an indirect fluorescent antibody test. 11 Statistical analysis. The t-test was used to compare the average daily weight gains for the 2 groups of pigs following exposure to PRRSV. After TGEV challenge, linear regression analysis was used to estimate the rate of weight gain for each pig. Then analysis of variance (ANOVA) was used to determine differences among the 4 treatment groups and least significant difference (LSD) was used for pairwise comparisons of the treatment groups.
Results
Clinical signs following PRRSV infection. No distinct clinical signs of upper or lower respiratory disease were observed in individual pigs infected with PRRSV (groups B and D; n ϭ 18). However, by day 4 postinfection (PI) with PRRSV, the PRRSV-infected pigs were huddled as a group and slow to respond to presence of the animal handler. The subdued nature of the PRRSV-infected pigs continued through the second 
week following PRRSV infection up to the time of challenge with TGEV. The PRRSV-infected pigs also had a reduced appetite. They showed an interest in fresh feed, but only the PRRSV-infected pigs left feed in their troughs between feedings. The inappetence of the PRRSV-infected pigs was also reflected in a lower rate of weight gain (Fig. 1 ). For the week following PRRSV infection, pigs (n ϭ 18) averaged a weight gain of 0.08 kg/day and increased their total weight by 14%. This weight gain was significantly less (P ϭ 0.0008) than that of control pigs (n ϭ 18), which gained 0.13 kg/day and increased their total weight by 25% ( Fig. 1 ). During the second week post-PRRSV infection, these differences in weight gain between the controls and the infected pigs were less pronounced. Mean body temperature profiles following PRRSV infection (treatment groups B and D) and TGEV challenge (treatment groups C and D) are shown in Fig.  2 . During the second week following PRRSV infection, almost all of the PRRSV-infected pigs were febrile; 15/18 and 16/18 PRRSV-infected pigs, respectively, had body temperatures Ͼ40 C (104 F) on days 9 and 10 PI (Fig. 2) . After the second week post-PRRSV infection, there was a slow continuous decline in the number of PRRSV-infected pigs that were febrile.
PRRSV lesions. At 15 days after primary infection with PRRSV, 1 pig from each group was necropsied. Compared to the 2 control pigs, both of the PRRSVinfected pigs showed enlarged lymph nodes and areas of generalized consolidation involving about 25-40% of the lung.
PRRSV viremia. Before intranasal exposure to PRRSV at 2 weeks of age, all 36 pigs in this study were negative for PRRSV antibody. PRRSV was recovered from the serum of all PRRSV-infected pigs by day 7, and thereafter it was recovered weekly from each PRRSV-infected pig except 1 during the first 4 weeks PI (Table 1) .
Clinical signs following TGEV challenge. Signs of TGEV morbidity were apparent for those pigs not having been exposed to PRRSV (group C, n ϭ 8) and for those pigs exposed to PRRSV 2 weeks prior to challenge with TGEV (group D, n ϭ 8). By day 2 postchallenge, pigs of groups C and D were inappetent and had a watery, gray, fetid diarrhea, and their hair coats were dirty as a result of the watery diarrhea on the raised decks. The PRRSV-infected group D pigs appeared to be quieter and more depressed (many pigs with their heads hanging and their eyes closed) than the TGEV-only challenged pigs. The hair coat of the PRRSV-infected pigs was rough, and these pigs had a ''stocky'' appearance compared to the TGEV-infected controls. After challenge exposure, only a few pigs from either group had a transient (1 day) elevated temperature Ͼ40 C (104 F) (Fig. 2) .
Weight patterns following TGEV challenge. The rate of weight gain following TGEV challenge exposure for all 4 treatment groups is shown in Fig. 3 . The A and B treatment groups that were not challenged (uninfected control pigs and PRRSV-only pigs) had a steady weight gain from day 0 to day 11 postchallenge. Three of eight group C pigs, given TGEV only, showed no apparent reduction in their rate of weight gain, similar to the controls and the PRRSV-only pigs. These 3 pigs, however, were infected by the challenge virus; they shed TGEV ( Table 2 ) and seroconverted to TGEV ( Table 3 ). The other 5 group C pigs either lost weight or only maintained their challenge-day weight until 5-7 days postchallenge, when all group C pigs began to recover and to gain weight again. In group D pigs infected with PRRSV followed by TGEV, 2 of 8 pigs were not severely affected by the TGEV challenge as seen by their steady gain in weight. The other 6 pigs were set back by the challenge (some were visibly thin with prominent backbone), and they all gained significantly less by day 11 postchallenge than did the control or PRRSV-only pigs (Fig. 3) . By the end of the first week or beginning of week 2 postchallenge, the group D pigs began to gain weight in a steady fashion.
Analysis of variance indicated that there were significant differences (P ϭ 0.0177) among the 4 treatment groups in terms of the rate of weight gain post-TGEV challenge. At the 5% significance level (P Յ 0.05), the rate of weight gain was not significantly different for group C pigs (TGEV only) as compared with pigs of groups A and B nor was it significantly different for pigs of groups C and D. However, rate of weight gain was significantly lower in group D pigs (PRRSV/TGEV) than in pigs of groups A and B but was not significantly different between group C and group D pigs.
TGEV shedding and seroconversion. Fecal shedding patterns were measured for the TGEV-only (group C) pigs and for the PRRSV/TGEV (group D) pigs ( Table 2 ). On day 1 postchallenge, TGEV was detected in 2/8 pigs in group C and in 1/8 pigs in group D. No virus was detected in either group by day 10 postchallenge. Six group D pigs shed Ͼ1,000 TCID 50 /ml during days 1-5 postchallenge, whereas only 2 pigs in the TGEV-only group shed Ͼ1,000 TCID 50 .
All pigs in both groups C and D seroconverted to TGEV by day 7 postchallenge (Table 3) . No noticeable differences in the serum neutralization SN titers between the 2 groups were observed either for the postchallenge day 7 serum samples or for the 2-week serum samples.
Discussion
Prior infection of young pigs with PRRSV at weaning at 2 weeks of age did not markedly affect the severity of enteric illness when the pigs were challenged 2 weeks later with TGEV. The TGEV-caused morbidity was measured by the onset, duration, and severity of clinical signs and weight loss and by TGEV shedding. Infection of weaned pigs with PRRSV had little or no obvious effect on their clinical response to infection with TGEV. Weight loss patterns of pigs in TGEV-only and PRRSV/TGEV pigs following TGEV challenge were variable but not significantly different. Some small differences in the time required for recovery and in the quantities of TGEV shed could be accounted for by the fact that PRRSV-infected pigs were in the convalescent phase of a mild respiratory illness. The observations from this study suggest that the systemic immune functions of PRRSV-infected pigs are not impaired.
No distinct clinical signs of respiratory disease were apparent in the 2-week-old PRRSV-infected pigs. In-stead, these pigs had more generalized signs of disease. They were listless and nonresponsive as compared with control pigs. They were inappetent and had rough hair coats and their appearance was ''stocky,'' perhaps resulting from a mild facial and generalized edema. No signs of coughing or dyspnea were seen; however, necropsy of 2 PRRSV-infected pigs 15 days following infection showed gross lung involvement, and lymph nodes were enlarged compared with those of 2 control pigs. Most of the PRRSV-infected pigs were febrile during the second week PI, but their body temperature profiles slowly returned to normal by the fourth week PI. In 10-week-old pigs given the Lelystad strain of PRRSV, only a transient fever was observed in the first few days after inoculation. 21 Mild, prolonged, recurrent fever was reported for 4-6-weekold SPF pigs infected with a Nebraska strain of PRRSV. 2 The prolonged, mild fevers in pigs in that study were similar to the results observed in 2-weekold pigs infected with PRRSV strain NADC-8.
PRRSV was recovered from all except 1 of the weekly serum samples obtained during the first 4 weeks following PRRSV infection (Table 1) . Four group B pigs and 4 group D pigs continued to be monitored for a PRRSV transmission study (W. L. Mengeling et al., unpublished data). By 5.5 weeks PI, PRRSV was still isolated from half of the serum samples but by 8 weeks PI no virus was recovered. However, pulmonary lavage samples from these 8 PRRSVinfected pigs still yielded PRRSV from 1 group B pig at 53 and 66 days PI.
Field observations and seroprevalence studies have suggested that PRRSV predisposes pigs to secondary respiratory pathogens and that respiratory complications, associated with PRRSV, occur in finishing/fattening units. Controlled experimental studies to test whether PRRSV potentiates other respiratory pathogens have been few and their results were contradictory. Previous studies showed that prior exposure to PRRSV was necessary for the occurrence of systemic disease due to Streptococcus suis serotype 2. 3 In contrast, other researchers were unable to demonstrate any potentiation caused by PRRSV for Haemophilus parasuis, S. suis, S. cholerasuis, and Pasteurella multocida. 2 Likewise, additional experiments have demonstrated that clinical signs or pathology due to Mycoplasma hyopneumoniae was not increased by prior PRRSV infection. 19 In terms of respiratory viral pathogens, sequential infections with PRRSV and then porcine respiratory coronavirus or with PRRSV followed later by swine influenza virus in both instances produced more severe clinical signs in pigs than when any of the 3 viruses were inoculated individually. 21 This synergism between viruses could result because each of the viruses infect different types of pulmonary cells, and thus they combine to produce a more severe disease. The study reported here was designed to test whether PRRSV caused a generalized impairment of recovery mechanisms. The TGEV-induced disease in these nursery-age pigs was not affected by prior PRRSV infection.
